Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

ADC Therapeutics doses first patient in Phase II trial of ADCT-402

Micrograph of a diffuse large B-cell lymphoma. Credit: Nephron.

Go Top